Factors | Results |
---|---|
Patient background | |
Cases | 19 Cases |
Age | 70.1 ± 8.8 years |
Sex | 13 Male, 6 female |
Blood samples | |
White blood cells | 7.34 ± 1.56 × 103/µL |
Red blood cells | 4.26 ± 0.68 × 106/µL |
Hemoglobin | 13.0 ± 1.8 g/dL |
Platelets | 288.5 ± 138.6 × 103/µL |
Total protein | 7.1 ± 0.65 g/dL |
Albumin | 3.96 ± 0.50 g/dL |
NSE | 29.5 ± 16.7 ng/mL |
CEA | 6.36 ± 5.85 ng/mL |
PET–CT | |
SUVmax in the hypothalamic/pituitary region | 3.47 ± 0.80 |
Total volume of hypothalamic/pituitary region | 0.52 ± 0.13 mL |
TLG of hypothalamic/pituitary region | 1.33 ± 0.33 SUV × mL |
SUVmax of the primary tumor | 13.3 ± 3.5 |
volume of the primary tumor | 42.0 ± 39.7 mL |
TLG of the primary tumor | 314.9 ± 348.0 SUV × mL |
Maximum diameter of primary tumor | 40.2 ± 19.0 mm |
SUVmax of the lymph node metastases | 11.6 ± 4.4 |
Volume of lymph node metastases | 29.6 ± 33.0 mL |
TLG of the lymph node metastases | 208.6 ± 263.0 SUV × mL |
Total tumor volume (primary tumor and lymph node metastases) | 70.1 ± 53.0 mL |
Total tumor TLG (primary tumor and lymph node metastases | 512.6 ± 461.4 SUV × mL |